Certara, Inc. is a leading healthcare company based in the United States that utilizes biosimulation software and technology to speed up the delivery of medicines to patients. By offering modeling and simulation, regulatory science, and assessment software and services, Certara helps clients minimize clinical trials, hasten regulatory approval, and improve patient access to medicines. With a low-risk ESG score of 16.6, Certara has a strong presence in the Americas, EMEA, and Asia Pacific regions.